[SEPAR (Spanish Society of Pneumology and Thoracic Surgery) Guidelines. Guideline for diagnosis and treatment of respiratory involvements in cystic fibrosis].
Máiz
L
L
Servicios de Neumología. Hospital Ramón y Cajal. Madrid. España. lmáiz@hrc.insalud.es
Baranda
F
F
Coll
R
R
Prados
C
C
Vendrell
M
M
Escribano
A
A
Gartner
S
S
de Gracia
S
S
Martínez
M
M
Salcedo
A
A
Vázquez
C
C
D000328:Adult; D000367:Age Factors; D000465:Algorithms; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000188:drug therapy / Q000209:etiology; D002648:Child; D003550:Cystic Fibrosis / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics / Q000534:rehabilitation / Q000628:therapy*; D003937:Diagnosis, Differential; D005081:Exercise Therapy; D005541:Forced Expiratory Volume; D005544:Forecasting; D006801:Humans; D007231:Infant, Newborn; D009154:Mutation; D018410:Pneumonia, Bacterial / Q000175:diagnosis / Q000188:drug therapy; D011030:Pneumothorax / Q000209:etiology / Q000628:therapy; D011379:Prognosis; D012106:Research; D012131:Respiratory Insufficiency / Q000209:etiology / Q000628:therapy; D012138:Respiratory Therapy
D000900:Anti-Bacterial Agents